Cite
HARVARD Citation
Bianzano, S. et al. (2023). Safety, tolerability, pharmacodynamics and pharmacokinetics following once‐daily doses of BI 187004, an inhibitor of 11 beta‐hydroxysteroid dehydrogenase‐1, over 28 days in patients with type 2 diabetes mellitus and overweight or obesity. Diabetes, obesity & metabolism. 25 (3), pp. 832-843. [Online].